Samrat Pharmachem has informed that board meeting to be held on Tuesday, the 13th day of February, 2018, for considering and taking on record the Un-Audited Financial Results of the Company as on 31/12/2017, as published in the Baroda Edition of 'Indian Express', English Edition & Vadodara Samachar, Gujarati Edition dated 18th January, 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1663.50 |
| Dr. Reddys Lab | 1224.65 |
| Cipla | 1235.80 |
| Zydus Lifesciences | 929.80 |
| Lupin | 2316.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: